Company Biocon Limited

Equities

BIOCON

INE376G01013

Biotechnology & Medical Research

Market Closed - NSE India S.E. 08:01:59 2024-03-28 am EDT 5-day change 1st Jan Change
264.2 INR +2.94% Intraday chart for Biocon Limited +7.01% +5.81%

Business Summary

Biocon Limited is an India-based biopharmaceutical company, which focuses on treating diabetes, cancer and autoimmune diseases. Its segment includes Generics, Biosimilars, Novel Biologics and Research Services. It has developed and commercialized novel biologics, biosimilars, and complex small molecule active pharmaceutical ingredients (APIs) in India and several key global markets, as well as Generic Formulations in the United Sates, Europe and key emerging markets. Its API portfolio includes cardiology, anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology and other key products. Its products include Tacrolimus, Rosuvastatin, Simvastatin, Atorvastatin, Pravastatin, Fingolimod and others. It has over five facilities across Bangalore, Hyderabad and Visakhapatnam in India. Its API manufacturing facilities leverage complex technology platforms that range from microbial fermentation, chromatographic purification, chemical synthesis, peptide synthesis and HPAPIs.

Number of employees: 16,545

Sales per Business

INR in Million2022Weight2023Weight Delta
Biosimilars
49.8 %
34,301 41.9 % 55,599 49.8 % +62.09%
Research
28.1 %
25,119 30.7 % 31,392 28.1 % +24.97%
Generics
22.0 %
21,910 26.8 % 24,559 22.0 % +12.09%
Novels
0.2 %
510 0.6 % 192 0.2 % -62.35%

Sales per region

INR in Million2022Weight2023Weight Delta
Rest of the World
37.4 %
21,468 26.2 % 41,791 37.4 % +94.67%
United States
37.1 %
29,946 36.6 % 41,430 37.1 % +38.35%
India
15.0 %
13,563 16.6 % 16,737 15.0 % +23.40%
Ireland
10.5 %
16,863 20.6 % 11,784 10.5 % -30.12%

Managers

Managers TitleAgeSince
Chief Executive Officer 46 13-04-30
Chief Executive Officer 65 22-12-11
Chairman 71 78-11-28
Chief Tech/Sci/R&D Officer - -
Compliance Officer - 11-12-31
Corporate Officer/Principal - 97-06-30
Corporate Officer/Principal - -
General Counsel - 18-02-02
Human Resources Officer 54 13-11-30

Members of the board

Members of the board TitleAgeSince
Chairman 71 78-11-28
Director/Board Member 69 99-12-31
Director/Board Member 59 18-07-26
Director/Board Member 76 16-04-26
Chief Executive Officer 65 22-12-11
Director/Board Member 66 22-04-27
Director/Board Member 31 21-10-31
Director/Board Member 58 23-08-31
Chief Executive Officer 46 13-04-30
Director/Board Member - 23-07-25

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,196,590,319 446,005,810 ( 37.27 %) 0 37.27 %

Shareholders

NameEquities%Valuation
484,581,970 40.36 % 1 616 M ₹
John Shaw
19.76 %
237,211,164 19.76 % 791 M ₹
Life Insurance Corporation of India (Investment Portfolio)
4.413 %
52,984,653 4.413 % 177 M ₹
SBI Funds Management Ltd.
2.521 %
30,267,788 2.521 % 101 M ₹
Arohi Asset Management Pte Ltd.
1.579 %
18,951,731 1.579 % 63 M ₹
13,200,000 1.099 % 44 M ₹
Mirae Asset Investment Managers (India) Pvt Ltd.
1.025 %
12,306,909 1.025 % 41 M ₹
quant Money Managers Ltd.
1.000 %
12,011,098 1.000 % 40 M ₹
Tata Asset Management Ltd.
0.5465 %
6,560,782 0.5465 % 22 M ₹
5,301,321 0.4416 % 18 M ₹

Holdings

NameEquities%Valuation
219,185,608 54.52% 1,867,338,636 $
2,316,134 10.54% 5,767,174 $

Company contact information

Biocon Ltd.

20th KM, Hosur Road Electronics City

560100, Bangalore

+91 80 2808 2808

http://www.biocon.com
address Biocon Limited(BIOCON)

Group companies

NameCategory and Sector
Miscellaneous Commercial Services
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Major
Biotechnology
Miscellaneous Commercial Services